Sponsor or institution
Clinical trials and research at GC Cell Corporation
As of November 12, 2026, Find a Trial lists 2 clinical trials run by GC Cell Corporation that are recruiting, in South Korea. By phase: Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Investigating GCC2005 for patients with relapsed/refractory NK and T-cell malignancies
This study is testing a new treatment called GCC2005 to see if it is safe and effective for people with certain types of blood cancers that have not responded to previous therapies.
-
Combining Immuncell-LC with Gemcitabine for Pancreatic Cancer Treatment
This study is testing if adding a new immunotherapy called Immuncell-LC to the chemotherapy drug gemcitabine can help people with operable pancreatic cancer do better than with gemcitabine alone.
Quick answers
How many clinical trials run by GC Cell Corporation are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.